Data privacy considerations for telehealth consumers amid COVID-19

Abstract

Abstract The COVID-19 emergency poses particularly high infection risks in a clinical setting, where patients and health care providers are placed in the same room. Due to these risks, patients are encouraged to avoid clinics and instead use Telemedicine for safer consultations and diagnoses. In March, the Office for Civil Rights (OCR) at the U.S. Department for Health and Human Services (HHS) issued a notice titled Notification of Enforcement Discretion for Telehealth Remote Communications During the COVID-19 Nationwide Public Health Emergency (the ‘Notification’). The Notification relaxes the enforcement of privacy and security safeguards established by the Health Insurance Portability and Accountability Act (HIPAA) until further notice, in order to facilitate the transition to telehealth services for the broader purpose of promoting public health during the pandemic. Specifically, covered healthcare providers can use telehealth to provide all services that, in their professional judgment, they believe can be provided through telehealth. If providers make good faith efforts to provide the most timely and accessible care possible, they will not be subject to penalties for breaching the HIPAA Privacy, Security, and Breach Notification Rules. This paper examines the implications of the Notification on patients’ health information privacy. It recommends that patients should undertake a careful reading of provider privacy policies to make sure their protected health information (PHI) is not at risk before switching to telehealth consultation. Acknowledging the limitations of patient self-protection from bad privacy practices when in need for medical treatment during pandemic, the paper proposes that consumers’ data privacy should be protected through one of two alternative regulatory interventions: the FTC’s authority under §5, or HIPAA’s business associates agreements.